Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  zorubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-21 of 21 for your search:
Start Over
Phase III Combination Chemotherapy with ARA-C/RBD/VCR/PRED for Adults with Chronic Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: MDA-DT-7978, NCI-V84-0021
Late Intensification with CROP (CTX/RBD/VCR/PRED) with or without Active Specific Immunotherapy for AML
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: MDA-DT-7745
Phase II Chemotherapy with Rubidazone for Children with Refractory Acute Lymphoblastic or Acute Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-7818, MDAR-313
Phase II Chemotherapy with Rubidazone for Solid Tumors in Children
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-7843
Phase II Combination Chemotherapy with Rubidazone and DTIC for Advanced Sarcomas and Mesotheliomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7625, MDAR-134
Phase II Combination Chemotherapy with ROAP - RBD/VCR/ARA-C/PRED for Acute Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 50
Sponsor: NCI
Protocol IDs: SWOG-7626
Phase II Chemotherapy with Rubidazone for Previously Treated Adults with Acute Leukemia or CML Blast Transformation
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-7633, MDAR-193
Phase II Chemotherapy with Rubidazone for Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI
Protocol IDs: SWOG-7726
Phase II Chemotherapy with Rubidazone for Lymphoma in Relapsing Patients Previously Untreated with Anthracycline Derivatives
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7734
Phase II ROAP (RBD/VCR/ARA-C/PRED) vs ADOAP (ADR/VCR/ARA-C/PRED) with Intensification and/or Immunotherapy for Acute Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: SWOG-7823/24/25/26
Phase II Study of Rubidazone for Advanced Carcinomas of the Lung, Adenocarcinomas of the Pancreas and Colon, and Other Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-22877
Phase II Chemotherapy with RBD vs ADR for Metastatic Breast Cancer in Previously Treated Patients
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-773201
Phase II Chemotherapy with ADR-DNA Complex vs ADR vs Rubidazone plus Immunotherapy with C. Parvum for Metastatic Breast Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7624
Phase I Chemotherapy with Intermittent Single High-Dose Rubidazone for Solid Tumors and Hematologic Malignancies
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7428
ROAP - Rubidazone/VCR/ARA-C/PRED plus MER-BCG Immunotherapy for Acute Nonlymphocytic Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: MDA-DT-7635A
ADOAP Induction plus ARA-C/TG Maintenance in PEPA with WBC Transfusions for Adult Acute Myelogenous Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: MDA-DT-7771
Chemotherapy with ROAP (RBD/VCR/ARA-C/PRED) plus Immunotherapy with MER for Acute Myelogenous Leukemia in Patients Over Age 50
Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: MDA-DT-7760
Combination Chemotherapy with ROAP (RBD/ARA-C/VCR/PRED), POMP (6-MP/VCR/MTX/PRED) and OAP (ARA-C/VCR/PRED) plus TG with or without MER for AML
Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: MDA-DT-7926
Induction by AZC/RBD and Maintenance by Repetitive Sequences of AZC/RBD, AZC/CTX, AZC/TG, AZC/VCR/DM for Acute Myelocytic Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7703
CROPAM Induction and ARA-C/6-TG Consolidation plus Autologous Bone Marrow Rescue and Antibiotics for Adult ALL, AUL, and LL
Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-7833
Combination Chemotherapy with Ifosfamide and Rubidazone in Acute Undifferentiated or Lymphoblastic Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7709
Start Over